Merck's 2Q16 Estimates: Expect Operational Growth in RevenuesMarket RealistAnalysts expect the operational increase in revenues will be substantially offset by the negative impact of foreign exchange.
Five diabetes drugs among top selling drugs in India - The Pharma Letter (registration)
The Pharma Letter (registration)Five diabetes drugs among top selling drugs in IndiaThe Pharma Letter (registration)Human Mixtard (insulin from Abbott), Glycomet GP (metformin), Lantus (insulin glargine from Sanofi), Galvus Met (vildagliptin from Novartis) and Janumet (sitagliptin/metformin from Merck & Co) are the five top selling anti-diabetics drugs.
Januvia and Janumet: Merck's Blockbuster Diabetes Drugs - Market .
Five diabetes drugs in top-10 selling list - Times of India - Times of India
Times of IndiaFive diabetes drugs in top-10 selling list - Times of IndiaTimes of IndiaMUMBAI: In perhaps a grim reminder of the growing incidence of lifestyle diseases, five out of the top 10 largest-selling drugs in the country are now .
Where Rutherford hospitals rank in doctors taking drug industry money - The Daily News Journal
The Daily News JournalWhere Rutherford hospitals rank in doctors taking drug industry moneyThe Daily News JournalAccording the to the ProPublica database, he received $41,690 for promotional speaking and consulting from Merck, which makes diabetes drugs Januvia and Janumet, and Eli Lilly, which makes diabetes drug Humalog.